Oxaliplit 100mg Injection oxaliplatin 100 mg

₹ 650/Vial

Dose/Strength100 mg /50 ml
Packaging TypeVial
Manufacturerzee laboratory limited
Brand NameOxaliplit 100mg
Compositionoxaliplatin 100 mg
AvailabilityIn Stock
View in Hindi ऑक्सालिप्लिट 100 मिलीग्राम इंजेक्शन ऑक्सालिपलाटिन 100 मिलीग्राम

Oxaliplit 100mg Injection consists of the active ingredient Oxaliplatin. It is prescribed to treat stage 3 colon cancer and colorectal cancer, along with other chemotherapy treatments. Colorectal cancer develops from the accumulation of various genetic alterations. Both environmental and genetic factors play a significant role in the origin of colorectal cancer. This medicine works against tumors that are resistant to cisplatin therapy.

 

Exports To: Nepal | Bangladesh | Sri Lanka | Italy | Indonesia

Find products similar to Oxaliplit 100mg Injection Oxaliplatin 100 Mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromMumbai
ShippingAs per delivery location

Product Video

Product Image

Oxaliplit 100mg Injection  oxaliplatin 100 mg-1Oxaliplit 100mg Injection  oxaliplatin 100 mg-2Oxaliplit 100mg Injection  oxaliplatin 100 mg-3Oxaliplit 100mg Injection  oxaliplatin 100 mg-4

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
05-07-2018
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
May 2019
GST
27ABIFM7514N1ZQ
Import Export Code (IEC)
ABIFM*****
Exports to
Nepal | Bangladesh | Sri Lanka | Italy | Indonesia
Established in the year 2007 at Mumbai, Maharashtra, We “Meditab Worldwide” are a Partnership based firm, engaged as the foremost Wholesale Trader of Pharmaceutical Injection, Pharmaceutical Tablets, etc. Our products are high in demand due to their premium quality and affordable prices. Furthermore, we ensure to timely deliver these products to our clients, through this, we have gained a huge clients base in the market.